Bayer pays out $15.9b to settle Roundup cancer claims | ABC News

Global pharmaceutical giant Bayer will spend up to $US10.9 billion ($15.87b) to settle thousands of lawsuits alleging the company’s weedkiller, Roundup, causes cancer. The Germany-based company, which bought Roundup maker Monsanto two years ago, said the settlement would cover about 95,000 cases.

Read more here: https://ab.co/2Yy5lEh

For more from ABC News, click here: https://ab.co/2kxYCZY
You can watch more ABC News content on iview: https://ab.co/2OB7Mk1

Subscribe to us on YouTube: http://ab.co/1svxLVE
Go deeper on our ABC News In-depth channel: https://ab.co/2lNeBn2
You can also like us on Facebook: http://facebook.com/abcnews.au
Or follow us on Instagram: http://instagram.com/abcnews_au
Or even on Twitter: http://twitter.com/abcnews


About This Source - ABC News (Australia)

The video item below is from ABC News (Australia). ABC News is a public news service in Australia produced by the News and Current Affairs division of the Australian Broadcasting Corporation.

Recent from ABC News (Australia):

Perth chef chris anca's kitchen supporting disadvantaged people through food | abc news 1

Perth chef Chris Anca’s kitchen supporting disadvantaged people through food | ABC News

South Australia residents still rebuilding a decade after blaze | ABC News

Indigenous leaders work for ‘peace’ amid violent unrest in NT | ABC News

In This Story: Bayer

Bayer AG is a German multinational pharmaceutical and life sciences company and one of the largest pharmaceutical companies in the world.

2 Recent Items: Bayer

Ontario class action lawsuit alleges common weedkiller causes cancer

Global National: Jan. 18, 2024 | Trudeau, Nunavut sign Canada’s largest land transfer deal to date

In This Story: Bayer AG

Bayer AG is a German multinational pharmaceutical and life sciences company and one of the largest pharmaceutical companies in the world.

Stock tickers: ( FWB: BAYN, DAX Component)

Founded in Barmen in 1863 as a dyestuffs factory, Bayer’s first and best-known product was aspirin. The firm controls brands including Claritin, Coppertone and Dr. Scholl’s, and in 2018, it acquired Monsanto, a leading producer of genetically engineered crops, for $63 billion.

4 Recent Items: Bayer AG

China’s innovations make drug sector thrive, says Bayer China CFO

Primodos Scandal: Germany to review pregnancy test drug after UK review

Bayer settles Roundup cancer lawsuits for up to $10.9 billion

Ousted U.S. Whistleblower Says Trump Downplayed Virus Concerns

In This Story: Germany

Germany, officially the Federal Republic of Germany, is a country in Central and Western Europe. It lies between the Baltic and North seas to the north, and the Alps to the south.

Germany is a federal parliamentary republic led by a chancellor. With over 83 million inhabitants of its 16 constituent states, it is the second-most populous country in Europe after Russia, as well as the most populous member state of the European Union. Its capital and largest city is Berlin, and its financial centre is Frankfurt; the largest urban area is the Ruhr.

5 Recent Items: Germany

Trolltunga: Norway’s Enchanting Natural Wonder Becomes a Premier Wedding Destination

Thousands in Hamburg rally against far-right ‘master plan’ | DW News

Beauty Blogger Murdered Look-alike She Found on Instagram to Fake Her Own Death: Prosecutor

Why is Germany supporting Israel at the ICJ? | The Take

Masters of the Air – Exclusive Behind the Scenes Clip (2024) Austin Butler, Tom Hanks

Leave a Comment

We don't require your email address, or your name, for anyone to leave a comment. If you do add an email address, you may be notified if there are replies to your comment - we won't use it for any other purpose. Please make respectful comments, which add value, and avoid personal attacks on others. Links are not allowed in comments - 99% of spam comments, attempt to post links. Please describe where people may find additional information - for example "visit the UN website" or "search Google for..." rather than posting a link. Comments failing to adhere to these guidelines will not be published.